Cargando…
High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies
Autores principales: | Boukli, Narjis, Le Mene, Melchior, Schnuriger, Aurélie, Cuervo, Nancy Stella, Laroche, Cécilia, Morand-Joubert, Laurence, Gozlan, Joël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587123/ https://www.ncbi.nlm.nih.gov/pubmed/32848041 http://dx.doi.org/10.1128/JCM.01352-20 |
Ejemplares similares
-
Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value
por: Schnuriger, Aurélie, et al.
Publicado: (2021) -
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2021) -
Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis
por: Liu, Wanbing, et al.
Publicado: (2020) -
Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
por: Lijia, Shao, et al.
Publicado: (2020) -
Performance of the LIAISON(®) SARS-CoV-2 Antigen Assay vs. SARS-CoV-2-RT-PCR
por: Fiedler, Melanie, et al.
Publicado: (2021)